Denali Therapeutics Inc.

NasdaqGS:DNLI Stock Report

Market Cap: US$4.2b

Denali Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:DNLI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Aug 24SellUS$200,401Alexander SchuthIndividual8,353US$24.78
20 Aug 24SellUS$41,085Steve KrognesIndividual1,727US$23.79
20 Aug 24SellUS$53,765Ryan WattsIndividual2,260US$23.79
20 Aug 24SellUS$58,357Carole HoIndividual2,453US$23.79
13 Aug 24SellUS$53,494Carole HoIndividual2,337US$22.89
13 Aug 24SellUS$52,006Alexander SchuthIndividual2,272US$22.89
13 Jun 24SellUS$14,992Steve KrognesIndividual688US$21.79
13 Feb 24SellUS$46,960Alexander SchuthIndividual2,716US$17.29
13 Feb 24SellUS$48,135Carole HoIndividual2,784US$17.29
13 Feb 24SellUS$165,794Ryan WattsIndividual9,589US$17.29
13 Feb 24SellUS$47,548Steve KrognesIndividual2,750US$17.29
10 Jan 24SellUS$88,785Carole HoIndividual4,668US$19.02
09 Jan 24SellUS$154,640Ryan WattsIndividual7,818US$19.78
05 Jan 24SellUS$339,695Ryan WattsIndividual17,483US$19.43
05 Jan 24SellUS$193,756Alexander SchuthIndividual9,972US$19.43
05 Jan 24SellUS$62,331Steve KrognesIndividual3,208US$19.43
05 Jan 24SellUS$193,756Carole HoIndividual9,972US$19.43

Insider Trading Volume

Insider Buying: DNLI insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of DNLI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders6,685,8464.5%
Public Companies12,751,3658.59%
Institutions129,031,88286.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.

Top Shareholders

Top 25 shareholders own 84.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.61%
Baillie Gifford & Co.
13,763,596US$405.1m-1.98%0.17%
9.2%
BlackRock, Inc.
13,174,562US$387.7m7.99%0.01%
8.91%
Biogen Inc.
12,751,365US$375.3m0%no data
7.9%
The Vanguard Group, Inc.
11,312,439US$332.9m3.14%no data
6.86%
Wellington Management Group LLP
9,823,767US$289.1m18.8%0.04%
5.02%
FMR LLC
7,191,945US$211.7m2,990%0.01%
4.98%
Capital Research and Management Company
7,126,533US$209.7m17.8%0.01%
3.99%
Temasek Holdings (Private) Limited
5,706,345US$167.9m0%0.13%
3.33%
Crestline Investors Inc.
4,760,732US$140.1m-8.64%10.33%
3.1%
State Street Global Advisors, Inc.
4,434,790US$130.5m-29.9%no data
2.61%
Baker Bros. Advisors LP
3,731,695US$109.8m0%0.84%
2.08%
Geode Capital Management, LLC
2,982,538US$87.8m8.08%0.01%
1.7%
UBS Asset Management AG
2,433,939US$71.6m136%0.01%
1.69%
Marshall Wace LLP
2,418,833US$71.2m12.7%0.11%
1.58%
T. Rowe Price Group, Inc.
2,255,470US$66.4m7.75%0.01%
1.57%
Ryan Watts
2,241,211US$66.0m0.12%no data
1.47%
Marc Tessier-Lavigne
2,111,441US$62.1m0.2%no data
1.41%
AllianceBernstein L.P.
2,018,534US$59.4m1,370%0.02%
1.4%
Camber Capital Management LP
2,000,000US$58.9m33.3%2.19%
1.07%
BNY Asset Management
1,525,754US$44.9m-13.5%0.01%
1.06%
Credit Suisse Asset Management (Switzerland) Ltd.
1,519,295US$44.7m0%0.03%
0.99%
Dimensional Fund Advisors LP
1,417,472US$41.7m6.34%0.01%
0.91%
Casdin Capital, LLC
1,300,000US$38.3m0%2.62%
0.85%
Citadel Advisors LLC
1,218,698US$35.9m-10.7%0.04%
0.8%
Yiheng Capital Management, L.P.
1,150,684US$33.9m0%3.39%